AC Followed by Pembrolizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cyclophosphamide and doxorubicin followed by pembrolizumab, used as a neoadjuvant or adjuvant treatment for HER-2 (EGFR2; ErbB2)-negative and hormone receptor-negative breast cancer.

**Synonyms:** - AC Plus Pembrolizumab Regimen - AC-Pembrolizumab Regimen - AC/Pembrolizumab Regimen - Adriamycin/Cytoxan Followed by Keytruda Regimen - Cyclophosphamide-Doxorubicin-Pembrolizumab - Cyclophosphamide-Doxorubicin-Pembrolizumab Regimen - Cyclophosphamide/Doxorubicin/Pembrolizumab - Cyclophosphamide/Doxorubicin/Pembrolizumab Regimen - Doxorubicin/Cyclophosphamide Followed by Pembrolizumab Regimen